First Trust Advisors »

Monte Rosa Therapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 648k 24.20

More positions owned by First Trust Advisors

Cisco Systems (CSCO)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Palo Alto Networks (PANW)
Applied Materials (AMAT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Fortinet (FTNT)
Kla Corp Com New (KLAC)
Lam Research Corp Com New (LRCX)
Crowdstrike Hldgs Cl A (CRWD)
Quanta Services (PWR)
Eaton Corp SHS (ETN)
Micron Technology (MU)

View all positions for First Trust Advisors

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
T. Rowe Price Associates
TCG Crossover Management
Vestal Point Capital
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Versant Venture Management
Braidwell
Geode Capital Management
American Century Companies
Marshall Wace

View all funds holding Monte Rosa Therapeutics